Crescentic forms of glomerulonephritis are characterized by the accumulation of fibrin and cells in Bowman's space and are associated with a rapid loss of renal function.
Introduction
Crescentic glomerulonephritis (GN) is usually associated with rapid onset, severe renal injury and a poor clinical prognosis. Immune-initiated injury within glomerular capillaries and mesangium promotes leukocyte recruitment, inflammatory glomerular injury, local fibrin deposition, increased permeability of the glomerular filtration barrier and the infiltration of inflammatory cells into Bowman's space. The combined impact of macrophage accumulation and epithelial proliferation in Bowman's space results in the formation of cellular crescents.
Crescentic GN has many of the features of a delayed-type hypersensitivity (DTH) response (23) , including prominent glomerular fibrin deposition (17) , and infiltration of macrophages (2) and CD4+ T cells (29) . Animal models have indicated that T cells are essential to the development of crescentic GN (13, 37) , with predominantly Th1-biased immune responses resulting in crescent formation (14, 15) . This suggests that Th1-directed, cell-mediated effector mechanisms, such as DTH, in association with coagulation pathway activation play a central role in the development of crescentic glomerular damage.
Accumulation of glomerular fibrin and up-regulation of glomerular procoagulant activity are consistent features of proliferative and crescentic forms of GN (6, 38) . Fibrin and/or fibrin degradation products (FDPs) may promote the development of crescentic GN through several mechanisms. First, the deposition of fibrin and/or fibrin/platelet microthrombi within glomerular capillaries may compromise filtration across the glomerular basement membrane, ultrafiltrate flow through Bowman's space and glomerular blood flow. Second, fibrin is apparently chemotactic for macrophages in Bowman's space (11) and may provide a supportive matrix for inflammatory and 4 epithelial cell migration and proliferation. Furthermore, FDPs are chem otactic for leukocytes (10, 27, 2 8) and may also influence macrophage accumulation in the glomerular tuft and Bowman's space. Studies with anti-coagulants and fibrinolytic agents, including heparin, warfarin, tPA and hirudin, have demonstrated that partial inhibition of glomerular fibrin deposition protects against the formation of crescents in experimental animals (3, 7, 40) . Finally, fibrin is reported to be an important mediator of injury in cutaneous DTH responses (5), with a direct role in macrophage recruitment (12) .
Perhaps the most provocative findings supporting a significant role of fibrin in GN are derived from studies of renal disease in mice and rabbits with either genetic or druginduced deficits in selected hemostatic factors. Elimination of key fibrinolytic system components in mice, including plasminogen activator or plasminogen, significantly increased glomerular fibrin, PAS-positive material, macrophages, and the propensity to form crescents, in an anti-GBM induced model of GN (18) . In addition, MMP-9-deficient mice were recently shown to be more susceptible to anti-GBM GN due to accumulated fibrin in the glomeruli (21) . In contrast, diminishing fibrinogen levels in rabbits with a snake venom component, ancrod, was shown to protect renal function, reduce glomerular inflammatory infiltrates into Bowman's space, and decrease crescent formation (22, 32, 34) . However, since ancrod results in an incomplete and temporary reduction of circulating fibrinogen (25) , and may increase the formation of circulating biologically active FDPs (8) , there remains significant uncertainty regarding the importance of fibrin(ogen) in promoting crescentic GN. Recent studies of anti-GBM induced GN in thrombin receptor (protease activator receptor-1; PAR-1)-deficient mice suggest that PAR-1 deficiency may protect against renal inflammation and crescentic GN in a manner that is at least partially independent of fibrin deposition (7). 
Materials and Methods

Induction of GN and tissue collection
Fibrinogen-deficient mice with a C57/BL6-inbred background were generated and genotyped as previously described (31 
Histological analysis
Four micron paraffin-embedded sections were cut and routinely stained with hematoxylin and eosin, Periodic acid-Schiff (PAS) and silver trichrome (Jones) stain. 
Assessment of renal function
Serum creatinine was assessed by the alkaline picric acid method with a Creatinine Kit (Sigma). Proteinuria was measured in urine samples, collected over 24 hours, using the Bradford assay (4).
Detection of circulating anti-sheep globulin antibodies
Anti-sheep globulin antibodies were measured by ELISA according to a previously published protocol (14) . Briefly, 96-well plates were coated with normal sheep globulin (prepared as described) (36) plates were read at 405 nm. In addition, IgG subtype analysis was performed on antisheep-specific Ig from plasma by ELISA as previously described (19).
Statistics
Results are expressed as mean S.E.M., except where indicated. Data were analyzed by Mann-Whitney U test for pairwise comparisons and ANOVA (analysis of variance) for multiple comparisons.
Results
Fibrinogen is a determinant of kidney disease and survival.
In order to directly test the prevailing hypothesis that fibrin deposition within glomeruli is an important factor in the development of crescentic glomerulonephritis, cohorts of Fib Figure 3A and B). In contrast, no fibrin(ogen)-related material was detected in the kidneys of Fib -/-mice ( Figure 3D ).
Assessment of glomerular deposition of PAS positive material
Glomeruli were graded on a scale of 0 -3 for PAS-positive material accumulation, 
Detection of circulating anti-sheep globulin antibodies
To demonstrate that equivalent systemic immune responses were generated in 
Assessment of renal function
Consistent with microscopically evident severe renal disease, serum creatinine levels were significantly higher in Fib +/ -mice (67.1 ± 8.5 µmol/L) than in Fib -/-mice (43.0 ± 2.5 µmol/L; p<0.03; Figure 4) . These values were both elevated above the baseline creatinine value of 23.6 ± 2.9 µmol/L, which was not different for Fib +/ -or Fib -/-mice.
Both Fib +/ -and Fib -/-mice developed significantly higher proteinuria than baseline levels. Glomerular procoagulant activity is elevated in crescentic GN and the activation of the coagulation and fibrinolytic systems have been shown to contribute to disease progression (9, 35). Up-regulation of tissue factor activity leading to thrombin-mediated platelet activation, fibrin polymer formation and the deposition of platelet-rich thrombi would be expected to promote glomerular damage and local inflammation. Consistent with this view, it has recently been demonstrated that administration of the specific thrombin inhibitor, hirudin, is highly protective against severe crescentic GN in mice (7).
This effect was found to be at least partly due to signaling through a thrombin receptor, protease-activated receptor-1 (PAR-1). However, it is likely that thrombin promotes GN through several of its known substrates, which include three G-protein coupled proteaseactivated receptors (PAR-1, -3 and -4), coagulation factors XI, VIII, V, XIII and 
